Table 2 The composition of DEG modules of GBM, including the number of DEGs, the number of effective DEGs, the dominant SGAs, and the proportion of co-regulations produced by each dominant SGA.
From: Tumour-specific Causal Inference Discovers Distinct Disease Mechanisms Underlying Cancer Subtypes
Module Index | # of DEG | # of Effective DEGs | Dominant SGAs (Prop. of Co-regulation) |
|---|---|---|---|
Module 1 | 413 | 255 | TP53 (99.69%) |
Module 2 | 128 | 72 | PTEN (50.0%), SEC61G (47.6%) |
Module 3 | 529 | 347 | CDKN2A (98.5%) |
Module 4 | 170 | 81 | MARCH9 (97.9%) |
Module 5 | 599 | 347 | PTEN (98.3%) |
Module 6 | 425 | 255 | SEC61G (98.8%) |
Module 7 | 11 | 7 | EGFR (68.9%), TP53 (31.0%) |
Module 8 | 242 | 150 | CDKN2B-AS1 (94.8%) |
Module 9 | 165 | 88 | AGAP2-AS1 (58.1%), CHIC2 (41.4%) |
Module 10 | 71 | 42 | CDKN2B (94.2%) |
Module 11 | 428 | 260 | EGFR (97.9%) |
Module 12 | 85 | 62 | CDKN2A (69.2%), PTEN (30.1%) |
Module 13 | 142 | 88 | GSX2 (75.0%), RYR2 (11.4%) |
Module 14 | 123 | 74 | MTAP (94.5%) |
Module 15 | 45 | 26 | TTN (91.9%) |
